Subjects: Drug Approval -- economics - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Drug Approval -- economics ✖

1. Economic analysis of availability of follow-on protein products: final report

Publication:: [Washington, DC] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2009
Subject(s):: Proteins -- economics
Biological Products
Drug Approval -- economics
United States

2. Generic drug user fees: application review times declined, but FDA should develop a plan for administering its unobligated user fees : report to the Chairman, Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:: Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):: Drugs, Generic -- economics
Drugs, Investigational -- economics
Investigational New Drug Application -- economics
Drug Approval -- economics
Humans
United States
United States. Food and Drug Administration.

3. Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, November 2017
Subject(s):: Drug Costs
Drug Industry -- economics
Economics, Pharmaceutical -- trends
Pharmaceutical Research -- economics
Pharmaceutical Research -- trends
Antitrust Laws
Biological Products -- economics
Drug Approval -- economics
Drug Development -- economics
Drug Development -- trends
Economic Competition
Forecasting
Orphan Drug Production -- economics
Taxes
Humans
United States
National Institutes of Health (U.S.)

4. Strengthening the accelerated approval pathway: an analysis of potential policy reforms and their impact on uncertainty, access, innovation, and costs

Author(s):: Kaltenboeck, Anna, author
Mehlman, Amanda, author
Pearson, Steven D., author
Publication:: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 26, 2021
Subject(s):: Drug Approval -- economics
Drug Approval -- legislation & jurisprudence
United States

5. Prescription Drug User Fee Act waivers, reductions, and refunds for drug and biological products

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, October 2019
Subject(s):: Drug Approval -- economics
Drug Approval -- legislation & jurisprudence
Investigational New Drug Application -- legislation & jurisprudence
Diffusion of Innovation
Economics, Pharmaceutical
Orphan Drug Production -- economics
Public Health
Small Business
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.